You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Litigation Details for Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (D. Del. 2017)

✉ Email this page to a colleague

« Back to Dashboard

Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (D. Del. 2017)

Docket	⤷ Sign Up	Date Filed	2017-04-07
Court	District Court, D. Delaware	Date Terminated	2019-01-01
Cause	35:271 Patent Infringement	Assigned To	Richard Gibson Andrews
Jury Demand	None	Referred To
Parties	MYLAN PHARMACEUTICALS INC.
Patents	7,297,703; 8,617,598; 8,778,962
Attorneys	Daniel M. Silver
Firms	Young, Conaway, Stargatt & Taylor LLP
Link to Docket	External link to docket

Small Molecule Drugs cited in Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc. (D. Del. 2017)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
2019-01-02	100		,778,962; 8,617,598; US 7,297,703 B2. (Attachments: # 1 Order)(nms) (Entered: 01/03/2019) 3 January… Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,665,772; 8,778,962…2017 2 January 2019 1:17-cv-00389 830 Patent None District Court, D. Delaware	External link to document
2017-04-07	3		Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 5,665,772; 8,778,962; 8,617,598. (crb) (…2017 2 January 2019 1:17-cv-00389 830 Patent None District Court, D. Delaware	External link to document
2017-11-06	37		(1) Novartiss Infringement Chart for U.S. Patent 7,297,703, (2) Novartiss First Set of Requests for Production…2017 2 January 2019 1:17-cv-00389 830 Patent None District Court, D. Delaware	External link to document
2018-03-12	47		Supplemental Infringement Chart Concerning U.S. Patent No. 8,617,598 filed by Novartis AG, Novartis Pharmaceuticals…2017 2 January 2019 1:17-cv-00389 830 Patent None District Court, D. Delaware	External link to document
2018-06-29	72	Opinion - Memorandum Opinion	quot;the ' 598 patent"), and 7,297,703 ("the ' 703 patent"). I held oral argument…for multiple terms in U.S. Patent Nos. 8,778,962, 8,617,598, and 7,297,703. Within five days the parties…of multiple terms in U.S. Patent Nos. 8,778,962 ("the ' 962 patent"), 8,617,598 ("…quot;It is a bedrock principle of patent law that the claims of a patent define the invention to which …construing patent claims, a court considers the literal language of the claim, the patent specification	External link to document
2018-09-24	85		M. Klibanov on the Infringement of U.S. Patent No. 8,617,598 By Defendant Mylan Pharmaceuticals Inc.;…William R. Roush Regarding Infringement Of U.S. Patent No. 5,665,772; (2) Opening Expert Report of Professor…Ess, M.D., Ph.D. Regarding Infringement of U.S. Patent No. 8,778,962 filed by Novartis AG, Novartis Pharmaceuticals…2017 2 January 2019 1:17-cv-00389 830 Patent None District Court, D. Delaware	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.